Delivery Order SPE2DB24D1104-SPE2DB25FXTF1
Award Date
10/9/24
Potential Completion Date
10/10/24
Potential Value
$70K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of OTEZLA 30 mg tablets in 60-count packages to the U.S. government. The contract has a ceiling value of $22,266.98 and an ultimate completion date of May 7, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is the primary agency responsible for providing logistics and acquisition support for medical commodities to the U.S. Armed Forces and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of OTEZLA 30 mg tablets to the Defense Logistics Agency (DLA). The $3,182.12 firm fixed-price delivery order has a completion date of June 4, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. is for the delivery of 4,563,386,270 units of Otezla 30 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $52,893.10 and a period of performance through January 22, 2024. The contract was awarded on January 20, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp. is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award to AmerisourceBergen Drug Corp is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,350.00, is a firm fixed-price delivery order with an ultimate completion date of August 7, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract without any set-aside designation. This contract award is likely part of a larger Indefinite...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Otezla 30 mg tablet 60s. The contract has a ceiling value of $13,903.04 and an ultimate completion date of November 29, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, under a delivery order contract type with a firm fixed price pricing structure. No set-aside designation was used for this award. AmerisourceBergen holds a...
This contract award to AmerisourceBergen Drug Corp Corporate Office Division is a $14,627.84 firm-fixed-price delivery order (SPE2DB22D3004|SPE2DB25FNF11) for the pharmaceutical product Otezla 30mg tablets from the Defense Logistics Agency (DLA). The award has an ultimate completion date of October 16, 2024. AmerisourceBergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, supporting various agencies and healthcare programs through its extensive...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $11,913.28 firm fixed-price delivery order is for the supply of 4,564,911,313 units of the medication Otezla 30 mg tablets. The contract has a completion date of June 17, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $8,851.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The award is a Delivery Order contract for the provision of 4,565,047,372 units of the pharmaceutical drug OTEZLA 30 MG TABLET 60S. The contract has a Firm Fixed Price pricing type and a completion date of July 2, 2024. This award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award is a delivery order worth $15,158.86 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, for the delivery of OTEZLA 30 MG TABLET 60S. The contract has a firm fixed price pricing type and an ultimate completion date of July 7, 2025. It is not set aside for any special program. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,028.75 firm fixed price delivery order contract is for the supply of Otezla 30 mg tablets. The contract has an ultimate completion date of September 25, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...